TREA

86698323 - MICROBAC

Follow

Information

  • Trademark
  • 86698323
  • Serial Number
    86698323
  • Registration Number
    4986679
  • Filing Date
    July 20, 2015
    9 years ago
  • Registration Date
    June 28, 2016
    8 years ago
  • Transaction Date
    July 04, 2023
    a year ago
  • Status Date
    July 03, 2023
    a year ago
  • Published for Opposition Date
    April 12, 2016
    8 years ago
  • Location Date
    July 03, 2023
    a year ago
  • Status Code
    701
  • Current Location
    TMO LAW OFFICE 112
    Employee Name
    DICKEY, ERICA G.J.
  • Attorney Docket Number
    MARB-54802
    Attorney Name
    Michelle E. Tochtrop
    Law Office Assigned Location Code
    M30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MICROBAC
Case File Statements
  • B00001: In the statement, line 19, "containing microorganisms and cultures of microorganisms" should be should be inserted after "products".
  • GS0051: Micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; Pharmaceutical products containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; Pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; Microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; Supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; Supplements, namely, dietary supplements for medical use and baby food, all the above containing liquid, solid, dried or freeze-dried microorganisms or concentrated cultures of probiotic microorganisms; ferments for medical purposes, all the foregoing being for medical and veterinary use only
  • PM0001: MICRO BACK
Case File Event Statements
  • 7/3/2023 - a year ago
    34 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED Type: NAS8
  • 7/3/2023 - a year ago
    33 - REGISTERED - SEC. 8 (6-YR) ACCEPTED Type: 8.OK
  • 6/20/2023 - a year ago
    32 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 2/7/2023 - a year ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/7/2023 - a year ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/7/2023 - a year ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/27/2022 - a year ago
    28 - TEAS SECTION 8 RECEIVED Type: ES8R
  • 6/28/2021 - 3 years ago
    27 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/31/2016 - 7 years ago
    26 - CORRECTION UNDER SECTION 7 ¿ PROCESSED Type: COC.
  • 8/1/2016 - 8 years ago
    25 - SEC 7 REQUEST FILED Type: AMD7
  • 10/31/2016 - 7 years ago
    24 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 8/1/2016 - 8 years ago
    23 - PAPER RECEIVED Type: MAIL
  • 6/28/2016 - 8 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/12/2016 - 8 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/12/2016 - 8 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/23/2016 - 8 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/9/2016 - 8 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 3/2/2016 - 8 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 3/2/2016 - 8 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/2/2016 - 8 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/2/2016 - 8 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/2/2016 - 8 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/2/2016 - 8 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/28/2016 - 8 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/28/2016 - 8 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/26/2016 - 8 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 1/13/2016 - 8 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/30/2015 - 8 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/30/2015 - 8 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/30/2015 - 8 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/29/2015 - 8 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/25/2015 - 9 years ago
    3 - NOTICE OF PSEUDO MARK E-MAILED Type: MPMK
  • 7/24/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/23/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP